These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209 [TBL] [Abstract][Full Text] [Related]
13. Allograft vasculopathy and death in a cardiac transplant patient with angiographically normal coronary arteries. Johnson TH; McDonald K; Nakhleh R; McGinn AL; Wilson RF; Olivari MT; Kubo SH Cathet Cardiovasc Diagn; 1991 Sep; 24(1):37-40. PubMed ID: 1913790 [TBL] [Abstract][Full Text] [Related]
14. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082 [TBL] [Abstract][Full Text] [Related]
15. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. Escobar A; Ventura HO; Stapleton DD; Mehra MR; Ramee SR; Collins TJ; Jain SP; Smart FW; White CJ Am J Cardiol; 1994 Nov; 74(10):1042-6. PubMed ID: 7977044 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients. Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT Transpl Int; 1993; 6(6):341-7. PubMed ID: 8297464 [TBL] [Abstract][Full Text] [Related]
17. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P; N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570 [TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256 [TBL] [Abstract][Full Text] [Related]
19. Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy. Mehra MR; Ventura HO; Stapleton DD; Karsan AK; Smart FW; Ramee SR; Collins TJ Am Heart J; 1997 Jun; 133(6):698-702. PubMed ID: 9200398 [TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and cardiac allograft vasculopathy. Colvin-Adams M; Harcourt N; Duprez D J Cardiovasc Transl Res; 2013 Apr; 6(2):263-77. PubMed ID: 23135991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]